- Home
- FGNX vs PRPO Comparison
FGNX vs PRPO Comparison
Compare FGNX & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | PRPO |
|---|---|---|
| Founded | 1932 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 42.0M |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FGNX | PRPO |
|---|---|---|
| Price | $7.54 | $31.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 107.2K | 106.9K |
| Earning Date | 05-19-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,023,000.00 | $24,049,000.00 |
| Revenue This Year | $650.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 20.70 | ★ 29.77 |
| 52 Week Low | $1.59 | $14.24 |
| 52 Week High | $15.10 | $33.63 |
Technical Indicators
Market Signals| Indicator | FGNX | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 77.06 |
| Support Level | $5.64 | $22.25 |
| Resistance Level | $7.71 | $33.63 |
| Average True Range (ATR) | 0.76 | 2.04 |
| MACD | -0.05 | 0.93 |
| Stochastic Oscillator | 63.89 | 91.59 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.
About PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.